Quest Pharmatech Stock Today
| QPTFF Stock | USD 0.01 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 28
|
Quest PharmaTech is trading at 0.0133 as of the 11th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0133. Quest PharmaTech has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of July 2023 and ending today, the 11th of December 2024. Click here to learn more.
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. The company has 169.13 M outstanding shares. More on Quest PharmaTech
Quest Pink Sheet Highlights
| CEO | Ragupathy Madiyalakan |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Quest PharmaTech [QPTFF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest PharmaTech's market, we take the total number of its shares issued and multiply it by Quest PharmaTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Quest PharmaTech classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 169.13 M outstanding shares.
Quest PharmaTech has accumulated about 518.76 K in cash with (170.78 K) of positive cash flow from operations.
Check Quest PharmaTech Probability Of Bankruptcy
Ownership AllocationQuest PharmaTech owns a total of 169.13 Million outstanding shares. Quest PharmaTech holds 16.8 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Quest Ownership Details
Quest Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Quest PharmaTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Other Information on Investing in Quest Pink Sheet
Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.